Suchergebnisse - Chen, Bingliang

Identification of a Gene Signature to Aid Treatment Decisions by Integrated Analysis of Mutated Genes Between Primary and Metastatic Prostate Cancer von Li, Qinyu, Xiao, Xueyan, Chen, Bingliang, Song, Guoda, Zeng, Kai, Miao, Jianping

Volltext Volltext Volltext

A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy von Kuang, Zhihui, Li, Li, Zhang, Pan, Chen, Bingliang, Wu, Min, Ni, Haiqing, Yi, Shuai, Zou, Jia, Liu, Junjian

Volltext Volltext Volltext

Preclinical characterization of Sintilimab, a fully human anti-PD-1 therapeutic monoclonal antibody for cancer von Zhang, Shuang, Zhang, Min, Wu, Weiwei, Yuan, Zhijun, Tsun, Andy, Wu, Min, Chen, Bingliang, Li, Jia, Miao, Xiaoniu, Miao, Xiaoliang, Liu, Xiaolin, Yu, Dechao, Liu, Junjian

Volltext Volltext Volltext

Lower Urinary Tract Symptoms and Sexual Dysfunction in Male: A Systematic Review and Meta-Analysis von Song, Guoda, Wang, Min, Chen, Bingliang, Long, Gongwei, Li, Hao, Li, Rui, Liu, Zhuo, Wei, Chao, Wang, Tao, Wang, Shaogang, Liu, Jihong, Zhang, Yucong, Liu, Xiaming

Volltext Volltext Volltext

Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit von Wang, Jie, Fei, Keke, Jing, Hua, Wu, Zhihai, Wu, Weiwei, Zhou, Shuaixiang, Ni, Haiqing, Chen, Bingliang, Xiong, Yan, Liu, Yanpeng, Peng, Bo, Yu, Dechao, Jiang, Haiping, Liu, Junjian

Volltext Volltext Volltext

Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody von Wang, Yan, Pan, Donghui, Huang, Chenrong, Chen, Bingliang, Li, Mingzhu, Zhou, Shuaixiang, Wang, Lizhen, Wu, Min, Wang, Xinyu, Bian, Yicong, Yan, Junjie, Liu, Junjian, Yang, Min, Miao, Liyan

Volltext Volltext Volltext

PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity von Jiang, Haiping, Ni, Haiqing, Zhang, Pan, Guo, Xiaoli, Wu, Min, Shen, Haoran, Wang, Jie, Wu, Weiwei, Wu, Zhihai, Ding, Jiazheng, Tang, Rong, Zhou, Shuaixiang, Chen, Bingliang, Yu, Michael, Jing, Hua, Liu, Junjian

Volltext Volltext Volltext

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity von Qiao, Yunqian, Qiu, Yangmin, Ding, Jie, Luo, Nana, Wang, Hao, Ling, Xiaomin, Sun, Jiya, Wu, Zhihai, Wang, Yisen, Liu, Yanpeng, Guo, Feifei, Sun, Ta, Shen, Wanwan, Zhang, Min, Wu, Dongdong, Chen, Bingliang, Xu, Wei, Wang, Xuan

Volltext Volltext Volltext

Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity von Liu, Huisi, Wu, Weiwei, Sun, Gangyu, Chia, Tiongsun, Cao, Lei, Liu, Xiaodan, Guan, Jian, Fu, Fenggen, Yao, Ying, Wu, Zhihai, Zhou, Shuaixiang, Wang, Jie, Lu, Jia, Kuang, Zhihui, Wu, Min, He, Luan, Shao, Zhiyuan, Wu, Dongdong, Chen, Bingliang, Xu, Wenqing, Wang, Zhizhi, He, Kaijie

Volltext Volltext Volltext